The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

Clinical trial NCT05056519 · UNKNOWN

Trial details

NCT number: NCT05056519
Sponsor: Changchun BCHT Biotechnology Co.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza Prevention

Start date: 2021-09-20
Primary completion: 2021-12-30
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.